Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer

Pancreatic cancer is a highly aggressive disease with poor prognosis. N6-methyladenosine (m6A) is critical for post-transcriptional modification of messenger RNA (mRNA) and long non-coding RNA (lncRNA). However, the m6A-associated lncRNAs (m6A-lncRNA) and their values in predicting clinical outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xinshuang, Dong, Peng, Yan, Yu, Liu, Fengjun, Wang, Hui, Lv, Yajuan, Song, Meijuan, Yao, Qingqiang, Hu, Sanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490671/
https://www.ncbi.nlm.nih.gov/pubmed/34621754
http://dx.doi.org/10.3389/fcell.2021.748442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490671/
https://www.ncbi.nlm.nih.gov/pubmed/34621754
http://dx.doi.org/10.3389/fcell.2021.748442

Ejemplares similares